Share chart Novartis
Extended chart
Simple chart
About Novartis
Novartis International AG — транснациональная фармацевтическая корпорация, вторая по величине в мире фармацевтическая компания, второй по размерам рыночной доли в Европе производитель фармацевтических препаратов. Компания работает в 140 странах со штаб-квартирой в Базеле, ШвейцарияMain settings
IPO date
1991-11-18
ISIN
US66987V1098
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
3.46
Дивиденд ао
3.99
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 3.83 | 4 |
| P/BV | 4.49 | 4 |
| P/E | 16.59 | 7 |
Efficiency
| Title | Value | Grade |
| ROA | 11.81 | 4 |
| ROE | 26.33 | 8 |
| ROIC | 27.51 | 8 |
Dividends
| Title | Value | Grade |
| Dividend yield | 3.46 | 8.65 |
| DSI | 1 | 10 |
| Average dividend growth | 5.21 | 8.68 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 1.51 | 7 |
| Debt/Ratio | 0.3057 | 10 |
| Debt/Equity | 0.7097 | 9 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 3.66 | 1 |
| Yield Ebitda, % | 20.35 | 4 |
| Yield EPS, % | 66.7 | 8 |
Dividends
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 120.77 $ | 0 $ | 0 $ | -0.66 % | 0 % | 0 % |
| Week | 118.02 $ | 118.07 $ | 120.77 $ | 1.65 % | 0 % | 0 % |
| Month | 112.5 $ | 109.59 $ | 120.77 $ | 6.64 % | 0 % | 0 % |
| Three month | 103.85 $ | 101.96 $ | 120.77 $ | 15.52 % | 0 % | 0 % |
| Half a year | 105.47 $ | 96.77 $ | 120.77 $ | 13.75 % | 0 % | 0 % |
| Year | 119.15 $ | 96.77 $ | 120.89 $ | 0.69 % | 0 % | 0 % |
| 3 years | 79.7 $ | 75.31 $ | 120.89 $ | 50.53 % | 0 % | 0 % |
| 5 years | 89.62 $ | 75.31 $ | 120.89 $ | 33.87 % | 0 % | 0 % |
| 10 years | 78.95 $ | 60.27 $ | 120.89 $ | 51.95 % | 0 % | 0 % |
| Year to date | 105.43 $ | 97.14 $ | 120.77 $ | 13.79 % | 0 % | 0 % |
Main owners
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Harry Kirsch | Chief Financial Officer | 4.02M | 1965 (60 years) |
| Dr. Klaus Moosmayer Ph.D. | Chief Ethics, Risk & Compliance Officer | 1.56M | 1968 (57 years) |
| Ms. Karen L. Hale | Chief Legal Officer | 2.36M | 1968 (57 years) |
| Dr. Robert Kowalski Pharm.D. | Chief People & Organization Officer | 2.12M | 1968 (57 years) |
| Dr. Steffen Lang Ph.D. | President of Operations | 2.35M | 1967 (58 years) |
| Mr. Victor Bulto | President of US | 3.3M | 1978 (47 years) |
| Dr. Vasant Narasimhan M.D. | Chief Executive Officer | 8.07M | 1976 (49 years) |
| Dr. Patrick Horber M.D. | President of International | 7.36M | 1970 (55 years) |
| Paul Penepent | Head of Group Financial Reporting and Accounting | N/A | |
| Ms. Sloan Simpson | Global Head of Investor Relations |
About company
Address: Switzerland, Basel, Lichtstrasse 35 - Open in google maps, Open in yandex maps
Website: http://www.novartis.com
Website: http://www.novartis.com
